VAERS reports by lot

Pfizer COVID-19 lot EWO183: VAERS reports

51 VAERS reports list lot EWO183 as a Pfizer COVID-19 vaccine, received between 2021-05-07 and 2024-09-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
51
Reports
16%
Marked serious
2
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6026%
Neurological3817%
Cardiac / Cardiovascular3214%
Gastrointestinal188%
Musculoskeletal177%
Respiratory136%
Dermatological (non-injection-site)136%
Allergic / Anaphylactic115%
Reproductive / Menstrual115%
Injection-site / Local reaction94%
Thrombotic / Hematological31%
Psychiatric / Neuropsychiatric21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York7
California6
Massachusetts4
Michigan4
Indiana3
Washington3
Oregon3
Pennsylvania3
Colorado3
Maryland2
New Jersey2
Texas2

Reports by month received

2021-0511
2021-064
2021-076
2021-089
2021-094
2021-105
2021-113
2021-123
2022-022
2022-032
2022-051
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.